Venous Thrombosis during Spaceflight

Q: What is the clinical evidence from this study?

Study design: Case Report. Population: Obstructive left internal jugular venous thrombosis (n=1). Intervention: Enoxaparin transitioned to apixaban.

Serena M. Auñón-Chancellor; James M. Pattarini; Stephan Moll; Ashot E. Sargsyan

doi:10.1056/nejmc1905875

January 1, 2020New England Journal of MedicineOpen Access

Venous Thrombosis during Spaceflight

View Full Paper

Ask AI

Bookmark

Share

Study Design

Type

Case Report (n=1)

PICO

P

Population

One astronaut who developed left internal jugular venous thrombosis during an International Space Station mission.

I

Intervention / Comparator

Enoxaparin transitioned to apixaban (Enoxaparin 1.5 mg/kg once daily (reduced to 1 mg/kg), then apixaban 5 mg twice daily)

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Auñón-Chancellor et al. (2020) conducted a case report in Obstructive left internal jugular venous thrombosis (n=1). Enoxaparin transitioned to apixaban was evaluated.

synapsesocial.com/papers/6a64a1a559d309261193c0b1 https://doi.org/10.1056/nejmc1905875

View Full Paper

Ask AI

Bookmark

Share

Venous Thrombosis during Spaceflight

Study Design

PICO

Ask about this paper

Abstract

Discussion

Cite This Study

Venous Thrombosis during Spaceflight

Study Design

PICO

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading